SB 773 Oklahoma Senate · 2026 Regular Session

Pharmacy benefit managers; modifying definitions; prohibiting certain circumstances; requiring nonpayment under providing venue for certain court proceeding; allowing Attorney General to obtain certain information. Effective date.

Oklahoma's SB 773 regulates pharmacy benefit managers (PBMs) by prohibiting unfair practices that affect independent pharmacies and patients. It requires PBMs to pay independent pharmacies the same reimbursement rate for identical drugs as they pay PBM-owned pharmacies, banning "spread pricing" where PBMs charge plans more than they pay pharmacies. The bill also prohibits PBMs from charging pharmacies fees for claim submission, network enrollment, or claims processing, and restricts retroactive payment reductions except for fraud or audit errors. These changes directly impact PBMs, pharmacies, and health plans operating in Oklahoma, aiming to ensure fairer payment practices. The bill was vetoed by the governor but overridden by the legislature on May 29, 2025.
Bill status vetoed 4 of 5 stages cleared
Introduction
Feb 2025
Committee Review
May 2025
Senate Passage
Mar 2025
House Passage
May 2025
Vetoed
May 2025
Introduced Feb 3, 2025 Vetoed May 29, 2025
Maddy AI version diff · 5 comparisons

What changed between versions

Floor (House) Floor (Senate) · 12 edits
MAJOR
The bill was revised from the House version to the Senate floor version, primarily updating the header information and refining the definitions of key terms related to pharmacy benefit managers (PBMs). The substantive policy content regarding PBM regulation appears to remain consistent, with the main differences being formatting and version tracking.
Scope change
The bill's scope remains focused on regulating pharmacy benefit managers and related entities in Oklahoma, with no substantive changes to the regulatory framework itself.
TECHNICAL

Header information changed from 'HOUSE OF REPRESENTATIVES' to 'SENATE FLOOR VERSION' with updated session date and bill type designation from 'ENGROSSED SENATE' to 'COMMITTEE SUBSTITUTE'.

DEFINITION

Definition of 'Covered entity' was expanded to include 'health program administered by the state in the capacity of providing health coverage' and 'employer, labor union, or other group of persons that provides health coverage to persons in this state'.

Definition of 'Pharmacy benefits manager' was expanded to include persons or entities acting on behalf of a PBM in contractual or employment relationships, as well as managed care companies, nonprofit hospitals, and health programs administered by state departments.

Definition of 'Pharmacy benefits management' was clarified to explicitly include negotiating pricing and terms with drug manufacturers and providers.

Definition of 'Provider' was expanded to include an agent or representative of a pharmacy, not just the pharmacy itself.

Definition of 'Retail pharmacy network' was added as a new term to clarify networks where pharmacies primarily fill prescriptions via retail storefront locations.

Definition of 'Rural service area' was added as a new term, defined as ZIP codes with population density less than 1,000 individuals per square mile.

Definition of 'Suburban service area' was added as a new term, defined as ZIP codes with population density between 1,000 and 3,000 individuals per square mile.

Definition of 'Urban service area' was added as a new term, defined as ZIP codes with population density greater than 3,000 individuals per square mile.

Definition of 'Spread pricing' was added as a new term to describe pricing models where the contracted price differs from the amount paid to pharmacies.

Exemption language was modified to clarify that self-funded employer health plans without third-party utilization and unrelated to the employer's own pharmacy are not considered PBM entities.

Exemption language was modified to clarify that pharmacies providing discount cards or programs for exclusive use at their own location are not considered PBM entities.

Floor votes · Senate Mar 25, 2025 · House May 5, 2025

How they voted

470
Passed · 2 other
Total votes 49
Mar 25, 2025
D Democratic9
8 Yea 1
88% Yea
R Republican40
39 Yea 1
97% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
27
Key actions
7
Committee
6
May 29, 2025
Vetoed
Veto override message received
lower
May 29, 2025
Vetoed
Veto overridden: Ayes: 47 Nays: 0
upper
May 12, 2025
Vetoed
Vetoed 05/10/2025
upper
May 5, 2025
Committee
Referred for enrollment
upper
May 5, 2025
Lower · Passed
Third Reading, Measure passed: Ayes: 88 Nays: 0
lower
Apr 15, 2025
Lower · Passed
CR; Do Pass Health and Human Services Oversight Committee
lower
Apr 9, 2025
Lower · Passed
Policy recommendation to the Health and Human Services Oversight committee; Do Pass Public Health
lower
Apr 1, 2025
Committee
Referred to Public Health
lower
Mar 26, 2025
Introduced
First Reading
lower
Mar 26, 2025
Upper · Passed
Engrossed to House
upper
Mar 25, 2025
Committee
Referred for engrossment
upper
Mar 25, 2025
Upper · Passed
Measure passed: Ayes: 45 Nays: 0
upper
Feb 20, 2025
Upper · Passed
Reported Do Pass, amended by committee substitute Business and Insurance committee; CR filed
upper
Feb 3, 2025
Introduced
First Reading
upper
2 primary · 0 co-sponsors

Sponsors